{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:35:19Z","timestamp":1761658519071,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jmii.2023.06.004","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T05:40:01Z","timestamp":1687671601000},"page":"970-976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Precipitating factors of bradycardia after remdesivir administration: ICU admission and cutoff value for declining heart rate"],"prefix":"10.1016","volume":"56","author":[{"given":"Yan-Zuo","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Zhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5925-2064","authenticated-orcid":false,"given":"Chia-Jui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2023.06.004_bib1","first-page":"9","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmii.2023.06.004_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.jmii.2023.06.004_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jmii.2020.09.002","article-title":"Remdesivir use in the coronavirus disease 2019 pandemic: a mini-review","volume":"54","author":"Yang","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2023.06.004_bib4","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmii.2021.05.011","article-title":"Clinical efficacy of antiviral agents against coronavirus disease 2019: a systematic review of randomized controlled trials","volume":"54","author":"Lai","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2023.06.004_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmii.2020.03.034","article-title":"Treatment options for COVID-19: the reality and challenges","volume":"53","author":"Jean","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"year":"2022","series-title":"Therapeutic management of nonhospitalized adults with COVID-19","key":"10.1016\/j.jmii.2023.06.004_bib6"},{"key":"10.1016\/j.jmii.2023.06.004_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe covid-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2023.06.004_bib8","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.jaccas.2020.08.025","article-title":"Marked sinus bradycardia associated with remdesivir in COVID-19: a case and literature review","volume":"2","author":"Gubitosa","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.jmii.2023.06.004_bib9","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1503\/cmaj.210300","article-title":"Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man","volume":"193","author":"Day","year":"2021","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.jmii.2023.06.004_bib10","first-page":"8","article-title":"Sinus bradycardia associated with remdesivir treatment in COVID-19: a case report and literature review","author":"Barkas","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jmii.2023.06.004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.02.013","article-title":"Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns","volume":"27","author":"Touafchia","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2023.06.004_bib12","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/jmv.26898","article-title":"Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19)","volume":"93","author":"Pallotto","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2023.06.004_bib14","first-page":"14","article-title":"Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: a retrospective cohort study","author":"Alsowaida","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jmii.2023.06.004_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.14740\/cr1377","article-title":"Bradyarrhythmia after remdesivir administration in SARS-CoV-2: a review of literature and meta-analysis of observational studies in epidemiology","volume":"13","author":"Al-Jammali","year":"2022","journal-title":"Cardiol Res"},{"year":"2022","series-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines","key":"10.1016\/j.jmii.2023.06.004_bib16"},{"key":"10.1016\/j.jmii.2023.06.004_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinf.2021.05.025","article-title":"Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)","volume":"83","author":"Pallotto","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2023.06.004_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.009811","article-title":"Remdesivir-induced bradycardia in COVID-19: a single center prospective study","volume":"14","author":"Attena","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jmii.2023.06.004_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijid.2021.09.036","article-title":"Safety and heart rate changes in Covid-19 patients treated with Remdesivir","volume":"112","author":"Brunetti","year":"2021","journal-title":"I Int J Infect Dis"},{"key":"10.1016\/j.jmii.2023.06.004_bib20","first-page":"1","article-title":"Remdesivir-induced bradycardia in patients hospitalized with SARS-CoV2 infection: a possible vagally-mediated mechanism","author":"Filtz","year":"2022","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jmii.2023.06.004_bib21","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.4187\/respcare.02437","article-title":"Profound bradycardia with decreased PEEP","volume":"58","author":"Wilcox","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.jmii.2023.06.004_bib22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1186\/s12879-021-06536-3","article-title":"Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients","volume":"21","author":"Dessie","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2023.06.004_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/FJC.0b013e3181e0f8b2","article-title":"The mechanism of the negative chronotropic and dromotropic actions of adenosine 5'-triphosphate in the heart: an update","volume":"56","author":"Pelleg","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jmii.2023.06.004_bib24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.14423\/SMJ.0000000000001519","article-title":"Remdesivir-induced bradycardia","volume":"116","author":"Kanagala","year":"2023","journal-title":"South Med J"},{"key":"10.1016\/j.jmii.2023.06.004_bib25","doi-asserted-by":"crossref","first-page":"104955","DOI":"10.1016\/j.antiviral.2020.104955","article-title":"Antiviral activity and safety of remdesivir against SARS-CoV-2\u00a0infection in human pluripotent stem cell-derived cardiomyocytes","volume":"184","author":"Choi","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jmii.2023.06.004_bib26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1113\/expphysiol.2011.063925","article-title":"Acute adenosine increases cardiac vagal and reduces sympathetic efferent nerve activities in rats","volume":"97","author":"da Silva","year":"2012","journal-title":"Exp Physiol"},{"key":"10.1016\/j.jmii.2023.06.004_bib27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s40261-022-01187-x","article-title":"Clinical characteristics and implications of bradycardia in COVID-19 patients treated with remdesivir: a single-center retrospective cohort study","volume":"42","author":"Schreiber","year":"2022","journal-title":"Clin Drug Invest"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223001184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223001184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:30:21Z","timestamp":1761658221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118223001184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1684118223001184"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2023.06.004","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precipitating factors of bradycardia after remdesivir administration: ICU admission and cutoff value for declining heart rate","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2023.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}